Supplementary Figure S3

1
Supplementary Figure S A B 0.1 ng/ml RANKL 1 ng/ml RANKL 10 ng/ml RANKL 0.1 ng/ml RANKL 1 ng/ml RANKL 10 ng/ml RANKL

description

A. 0.1 ng/ml RANKL. 1 ng/ml RANKL. 10 ng/ml RANKL. B. 0.1 ng/ml RANKL. 1 ng/ml RANKL. 10 ng/ml RANKL. Supplementary Figure S3. - PowerPoint PPT Presentation

Transcript of Supplementary Figure S3

Page 1: Supplementary Figure S3

Supplementary Figure S3

A

B

0.1 ng/ml RANKL 1 ng/ml RANKL 10 ng/ml RANKL

0.1 ng/ml RANKL 1 ng/ml RANKL 10 ng/ml RANKL

Supplementary figure 5

Supplementary figure 5

Supplementary Figure 1

Supplementary Figure 1

Supplementary Figure Legends

Supplementary Figure Legends

Supplementary figure S1.

Supplementary figure S1.

Supplementary Figure 1. Supplementary Figure 2 Supplementary Figure 3 A B.

Supplementary Figure 1. Supplementary Figure 2 Supplementary Figure 3 A B.

Supplementary Figure S1: Synthesis of PIM-1 polymer. TTSBI ... · Supplementary Figure S3: Cross-sectional morphology of dense membranes. (a) Dense PIM-1 membrane (~50 µm), (b) UV

Supplementary Figure S1: Synthesis of PIM-1 polymer. TTSBI ... · Supplementary Figure S3: Cross-sectional morphology of dense membranes. (a) Dense PIM-1 membrane (~50 µm), (b) UV

Supplementary figure 1A

Supplementary figure 1A

Supplementary figure 2.

Supplementary figure 2.

Supplementary information for: Discovery and … · Supplementary Figure S2 Supplementary Figure S3 Supplementary Figure S4 Supplementary Figure S5 Supplementary Figure S6 Supplementary

Supplementary information for: Discovery and … · Supplementary Figure S2 Supplementary Figure S3 Supplementary Figure S4 Supplementary Figure S5 Supplementary Figure S6 Supplementary

SUPPELEMNTARY TABLE 1 · Web view8 Supplementary Figure S2 9 Supplementary Figure S3 10 SUPPLEMENTARY METHODS 13 References 14 GERAD1 author list Supplementary Table S1. Association

SUPPELEMNTARY TABLE 1 · Web view8 Supplementary Figure S2 9 Supplementary Figure S3 10 SUPPLEMENTARY METHODS 13 References 14 GERAD1 author list Supplementary Table S1. Association

Supplementary Figure 1 - Welcome to the UCLA …€¦ ·  · 2016-06-151 Supplementary Figure 1 Supplementary Figure 1. ... Supplementary Figure 5 Supplementary Figure 5. ... JP10089

Supplementary Figure 1 - Welcome to the UCLA …€¦ ·  · 2016-06-151 Supplementary Figure 1 Supplementary Figure 1. ... Supplementary Figure 5 Supplementary Figure 5. ... JP10089

Supplementary FIGURE 3

Supplementary FIGURE 3

Supplementary Figure 2A

Supplementary Figure 2A

Supplementary Figure S1 A B MTT MTT LDH activity 1100 · A B MTT LDH activity C. Supplementary Figure S2. Supplementary Figure S3 A B 0 2 4 6 8 relative chemotactic index - + + +

Supplementary Figure S1 A B MTT MTT LDH activity 1100 · A B MTT LDH activity C. Supplementary Figure S2. Supplementary Figure S3 A B 0 2 4 6 8 relative chemotactic index - + + +

Supplementary Figure 2

Supplementary Figure 2

Supplementary Figure S26.

Supplementary Figure S26.

Supplementary Figure 1A HNF4AWNT5AVANGL1PCLB1 Supplementary Figure 1B Supplementary Figure 1. (A) HNF4A TFBSs of the three genes: VANGL1, WNT5A and PLCB1.

Supplementary Figure 1A HNF4AWNT5AVANGL1PCLB1 Supplementary Figure 1B Supplementary Figure 1. (A) HNF4A TFBSs of the three genes: VANGL1, WNT5A and PLCB1.

Supplementary figure 1

Supplementary figure 1

Supplementary figure 1

Supplementary figure 1

Supplementary Figure S1

Supplementary Figure S1